/IROGENETICS 
TAB 
SUMMARY OF TROVAC APPENDICES 
A 
"Fowlpox virus based recombinant vaccines", Taylor, et al., Technological 
Advances in Vaccine Development, (ed. Laurence Lasky) Alan R. Liss, Inc., 
NY, 1988, pp 321-334. 
B 
"Recombinant fowlpox virus inducing protective immunity in non-avian 
species", Taylor, et al, Vaccine, 6:497-503, 1988. 
C 
"The use of fowlpox virus vectors to vaccinate non-avian species", Taylor, et 
al.. The Release of Genetically-engineered Micro-organisms, (eds. M. 
Sussman, C.H. Collins, F.A. Skinner, D.E. Stewart-Tull) Academic Press, 
San Diego, CA, 1988, pp 89-103. 
D 
"Immunity to fowlpox", Tripathy, et al., American Journal of Veterinary 
Research, 36:541-544, 1975. 
E 
"Fowlpox virus as a vector in non-avian species", Taylor, et al., Vaccine, 
6:466-468, 1988 (review). 
F 
"Protective immunity against avian influenza induced by a fowlpox virus 
recombinant", Taylor, et al., Vaccine, 6:504-508, 1988. 
G 
A report on an experiment to compare swine reactions following intradermal 
inoculations of both parental fowlpox and recombinants, showing no 
clinically significant reactivity (Rhone Merieux report #BL/AR-DRV 
499.88). 
H 
Results of a safety study done in chicken embryos, 1-day hatchlings, and 28- 
day chicks, showing TROVAC-RG (vFP6) to have no abnormal effect on any 
of the three paradigms (Rhone Merieux report #JFB/AR-DRV 411.88). 
I 
"Newcastle disease virus fusion protein expressed in a fowlpox virus 
recombinant confers protection in chickens", Taylor, et al., J. Virology, 
64:1441-1450, 1990. 
J 
"Protection of chickens with a recombinant fowlpox virus expressing the 
Newcastle disease virus hemagglutinin-neuraminidase gene", Edbauer, et al., 
Virology, 179:901-904, 1990. 
K 
Letter from Dr. Joseph Chen of USDA/ APHIS, assigning BL1 containment 
level to the fowlpox recombinant NDV vaccine, vFP96. 
Recombinant DNA Research, Volume 18 
[163] 
